Azacitidine in the treatment of blastic plasmacytoid dendritic cell neoplasm: a report of 3 cases

Leuk Lymphoma. 2016 Nov;57(11):2720-2. doi: 10.3109/10428194.2016.1160084. Epub 2016 Mar 17.

Authors

Raida Khwaja¹, Andrew Daly¹, Michael Wong¹, Etienne Mahé¹, Sonia Cerquozzi², Carolyn Owen¹

Affiliations

¹ a Cumming School of Medicine , Tom Baker Cancer Centre, University of Calgary , Calgary , Alberta , Canada ;
² b Division of Hematology , Mayo Clinic , Rochester , MN , USA.

PMID: 26984056
DOI: 10.3109/10428194.2016.1160084

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Aged, 80 and over
Azacitidine / therapeutic use*
Dendritic Cells / drug effects
Dendritic Cells / pathology*
Female
Humans
Male
Myeloproliferative Disorders / drug therapy*
Myeloproliferative Disorders / pathology
Neoadjuvant Therapy
Treatment Outcome

Substances

Azacitidine